RMGC,RMG Acquisition Corp. III | Financials

Financials

RMGC

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

RMG Acquisition Corp. IIIRMGC

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

RMG Acquisition Corp. III does not have significant operations.

It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

RMG Acquisition Corp. III was incorporated in 2020 and is based in Miami Beach, Florida. RMG Acquisition Corp. III operates as a subsidiary of RMG Sponsor III, LLC.

Latest News >

CVS to expand program aimed at reducing hospital readmissions for Medicare members

Sep 22, 2025

NEW YORK, Sept 22 (Reuters) - CVS Health's ( CVS ) Aetna insurance arm will expand a nascent program pairing members in its privately run Medicare plans with nurses - an effort the company says will reduce hospital readmissions, which are costly and can be detrimental to patient health. For patients on the Medicare Advantage plans for people 65 and...

Market Chatter: Tech, Finance Companies Scrambled to Adapt to New H-1B Visa Rules

Sep 22, 2025

06:52 AM EDT, 09/22/2025 (MT Newswires) -- Microsoft ( MSFT ) , Alphabet (GOOG, GOOGL), Amazon.com ( AMZN ) , and Goldman Sachs ( GS ) were among the tech companies and banks that sent urgent letters to employees urging them to stay home or quickly return to the US after the White House on Friday announced new rules on...

Oklo Breaks Ground on Idaho Nuclear Reactor Site Under US DOE Pilot Program

Sep 22, 2025

06:52 AM EDT, 09/22/2025 (MT Newswires) -- Oklo ( OKLO ) said Monday it will break ground on its fast fission power plant in Idaho under a US Department of Energy program to speed development of nuclear reactors. The plant, known as Aurora-INL, will be a sodium-cooled fast reactor using metal fuel, based on the Experimental Breeder Reactor II. The...

Merck Says US FDA Approves Keytruda Qlex Subcutaneous Injection

Sep 22, 2025

06:51 AM EDT, 09/22/2025 (MT Newswires) -- Merck ( MRK ) said Monday the US Food and Drug Administration has approved Keytruda Qlex subcutaneous injection for treating adults with solid tumors. The company said the injection is approved for 38 indications and can be administered in one minute every three weeks or two minutes every six weeks. The drugmaker said...